Follicle-stimulating hormone inhibits the constitutive release of insulin-like growth factor binding proteins by cultured rat ovarian granulosa cells

E. Y. Adashi, Carol E. Resnick, E. R. Hernandez, A. Hurwitz, Ronald (Ron) Rosenfeld

Research output: Contribution to journalArticle

72 Citations (Scopus)

Abstract

The ovarian granulosa cell has previously been shown to be a site of insulin-like growth factor (IGF)-I production, reception, and action. It is the purpose of this communication to explore the possibility that this cell type is also capable of hormonally-regulatable elaboration of IGF binding proteins (BPs). To this end, granulosa cells from immature, diethylstilbestrol-primed rats were cultured for up to 72h under serum-free conditions in the absence or presence of FSH (100ng/ml). Media conditioned by untreated granulosa cells revealed constitutively released polyethylene glycol (PEG)-precipitable [125I] IGF-I binding activity the daily elaboration of which proved constant throughout the 72h experimental period. However, treatment of granulosa cells with FSH resulted In dramatic inhibition of the accumulation of IGF-I binding activity (89% at the 100ng/ml dose level). Systemic provision of FSH (10μg/rat/day for 2 days) revealed that this gonadotropic action is not strictly an in vitro phenomenon but that it can be fully reproduced under in vivo circumstances. Western ligand blotting of SDS-PAGE-fractionated media conditioned by untreated granulosa cells revealed three IGF-BP species comprising a major band doublet (28-29kDa) as well as a single minor band (23kDa). Treatment with FSH virtually eliminated the 23kDa species and substantially reduced the relative representation ot the 28 and 29kDa IGF-BP species (82 and /4% inhibition, respectively). Taken together, these observations disclose the multiplicity of granulosa cell-derived IGF-BPs and reveal the striking ability ot FSH to suppress their constitutive release under both in vitro and in vivo circumstances. This FSH action is all the more noteworthy in light of the generally stimulatory effect exerted by FSH at the level ot the granulosa cell. Inasmuch as FSH may be concerned with the promotion of granulosa cell development, its ability to attenuate the release of (presumptively inhibitory) IGF-BPs may enhance the access of endogenously-produced IGF-I to its cognate cell surface receptors and hence its cellular hormonal action.

Original languageEnglish (US)
Pages (from-to)1305-1307
Number of pages3
JournalEndocrinology
Volume126
Issue number2
StatePublished - Feb 1990
Externally publishedYes

Fingerprint

Insulin-Like Growth Factor Binding Proteins
Granulosa Cells
Follicle Stimulating Hormone
Insulin-Like Growth Factor I
Conditioned Culture Medium
Diethylstilbestrol
Cell Surface Receptors
Polyacrylamide Gel Electrophoresis
Western Blotting
Ligands

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Adashi, E. Y., Resnick, C. E., Hernandez, E. R., Hurwitz, A., & Rosenfeld, R. R. (1990). Follicle-stimulating hormone inhibits the constitutive release of insulin-like growth factor binding proteins by cultured rat ovarian granulosa cells. Endocrinology, 126(2), 1305-1307.

Follicle-stimulating hormone inhibits the constitutive release of insulin-like growth factor binding proteins by cultured rat ovarian granulosa cells. / Adashi, E. Y.; Resnick, Carol E.; Hernandez, E. R.; Hurwitz, A.; Rosenfeld, Ronald (Ron).

In: Endocrinology, Vol. 126, No. 2, 02.1990, p. 1305-1307.

Research output: Contribution to journalArticle

Adashi, EY, Resnick, CE, Hernandez, ER, Hurwitz, A & Rosenfeld, RR 1990, 'Follicle-stimulating hormone inhibits the constitutive release of insulin-like growth factor binding proteins by cultured rat ovarian granulosa cells', Endocrinology, vol. 126, no. 2, pp. 1305-1307.
Adashi, E. Y. ; Resnick, Carol E. ; Hernandez, E. R. ; Hurwitz, A. ; Rosenfeld, Ronald (Ron). / Follicle-stimulating hormone inhibits the constitutive release of insulin-like growth factor binding proteins by cultured rat ovarian granulosa cells. In: Endocrinology. 1990 ; Vol. 126, No. 2. pp. 1305-1307.
@article{d34b33c1408a4b48be19bad4b04faf41,
title = "Follicle-stimulating hormone inhibits the constitutive release of insulin-like growth factor binding proteins by cultured rat ovarian granulosa cells",
abstract = "The ovarian granulosa cell has previously been shown to be a site of insulin-like growth factor (IGF)-I production, reception, and action. It is the purpose of this communication to explore the possibility that this cell type is also capable of hormonally-regulatable elaboration of IGF binding proteins (BPs). To this end, granulosa cells from immature, diethylstilbestrol-primed rats were cultured for up to 72h under serum-free conditions in the absence or presence of FSH (100ng/ml). Media conditioned by untreated granulosa cells revealed constitutively released polyethylene glycol (PEG)-precipitable [125I] IGF-I binding activity the daily elaboration of which proved constant throughout the 72h experimental period. However, treatment of granulosa cells with FSH resulted In dramatic inhibition of the accumulation of IGF-I binding activity (89{\%} at the 100ng/ml dose level). Systemic provision of FSH (10μg/rat/day for 2 days) revealed that this gonadotropic action is not strictly an in vitro phenomenon but that it can be fully reproduced under in vivo circumstances. Western ligand blotting of SDS-PAGE-fractionated media conditioned by untreated granulosa cells revealed three IGF-BP species comprising a major band doublet (28-29kDa) as well as a single minor band (23kDa). Treatment with FSH virtually eliminated the 23kDa species and substantially reduced the relative representation ot the 28 and 29kDa IGF-BP species (82 and /4{\%} inhibition, respectively). Taken together, these observations disclose the multiplicity of granulosa cell-derived IGF-BPs and reveal the striking ability ot FSH to suppress their constitutive release under both in vitro and in vivo circumstances. This FSH action is all the more noteworthy in light of the generally stimulatory effect exerted by FSH at the level ot the granulosa cell. Inasmuch as FSH may be concerned with the promotion of granulosa cell development, its ability to attenuate the release of (presumptively inhibitory) IGF-BPs may enhance the access of endogenously-produced IGF-I to its cognate cell surface receptors and hence its cellular hormonal action.",
author = "Adashi, {E. Y.} and Resnick, {Carol E.} and Hernandez, {E. R.} and A. Hurwitz and Rosenfeld, {Ronald (Ron)}",
year = "1990",
month = "2",
language = "English (US)",
volume = "126",
pages = "1305--1307",
journal = "Endocrinology",
issn = "0013-7227",
publisher = "The Endocrine Society",
number = "2",

}

TY - JOUR

T1 - Follicle-stimulating hormone inhibits the constitutive release of insulin-like growth factor binding proteins by cultured rat ovarian granulosa cells

AU - Adashi, E. Y.

AU - Resnick, Carol E.

AU - Hernandez, E. R.

AU - Hurwitz, A.

AU - Rosenfeld, Ronald (Ron)

PY - 1990/2

Y1 - 1990/2

N2 - The ovarian granulosa cell has previously been shown to be a site of insulin-like growth factor (IGF)-I production, reception, and action. It is the purpose of this communication to explore the possibility that this cell type is also capable of hormonally-regulatable elaboration of IGF binding proteins (BPs). To this end, granulosa cells from immature, diethylstilbestrol-primed rats were cultured for up to 72h under serum-free conditions in the absence or presence of FSH (100ng/ml). Media conditioned by untreated granulosa cells revealed constitutively released polyethylene glycol (PEG)-precipitable [125I] IGF-I binding activity the daily elaboration of which proved constant throughout the 72h experimental period. However, treatment of granulosa cells with FSH resulted In dramatic inhibition of the accumulation of IGF-I binding activity (89% at the 100ng/ml dose level). Systemic provision of FSH (10μg/rat/day for 2 days) revealed that this gonadotropic action is not strictly an in vitro phenomenon but that it can be fully reproduced under in vivo circumstances. Western ligand blotting of SDS-PAGE-fractionated media conditioned by untreated granulosa cells revealed three IGF-BP species comprising a major band doublet (28-29kDa) as well as a single minor band (23kDa). Treatment with FSH virtually eliminated the 23kDa species and substantially reduced the relative representation ot the 28 and 29kDa IGF-BP species (82 and /4% inhibition, respectively). Taken together, these observations disclose the multiplicity of granulosa cell-derived IGF-BPs and reveal the striking ability ot FSH to suppress their constitutive release under both in vitro and in vivo circumstances. This FSH action is all the more noteworthy in light of the generally stimulatory effect exerted by FSH at the level ot the granulosa cell. Inasmuch as FSH may be concerned with the promotion of granulosa cell development, its ability to attenuate the release of (presumptively inhibitory) IGF-BPs may enhance the access of endogenously-produced IGF-I to its cognate cell surface receptors and hence its cellular hormonal action.

AB - The ovarian granulosa cell has previously been shown to be a site of insulin-like growth factor (IGF)-I production, reception, and action. It is the purpose of this communication to explore the possibility that this cell type is also capable of hormonally-regulatable elaboration of IGF binding proteins (BPs). To this end, granulosa cells from immature, diethylstilbestrol-primed rats were cultured for up to 72h under serum-free conditions in the absence or presence of FSH (100ng/ml). Media conditioned by untreated granulosa cells revealed constitutively released polyethylene glycol (PEG)-precipitable [125I] IGF-I binding activity the daily elaboration of which proved constant throughout the 72h experimental period. However, treatment of granulosa cells with FSH resulted In dramatic inhibition of the accumulation of IGF-I binding activity (89% at the 100ng/ml dose level). Systemic provision of FSH (10μg/rat/day for 2 days) revealed that this gonadotropic action is not strictly an in vitro phenomenon but that it can be fully reproduced under in vivo circumstances. Western ligand blotting of SDS-PAGE-fractionated media conditioned by untreated granulosa cells revealed three IGF-BP species comprising a major band doublet (28-29kDa) as well as a single minor band (23kDa). Treatment with FSH virtually eliminated the 23kDa species and substantially reduced the relative representation ot the 28 and 29kDa IGF-BP species (82 and /4% inhibition, respectively). Taken together, these observations disclose the multiplicity of granulosa cell-derived IGF-BPs and reveal the striking ability ot FSH to suppress their constitutive release under both in vitro and in vivo circumstances. This FSH action is all the more noteworthy in light of the generally stimulatory effect exerted by FSH at the level ot the granulosa cell. Inasmuch as FSH may be concerned with the promotion of granulosa cell development, its ability to attenuate the release of (presumptively inhibitory) IGF-BPs may enhance the access of endogenously-produced IGF-I to its cognate cell surface receptors and hence its cellular hormonal action.

UR - http://www.scopus.com/inward/record.url?scp=0025019742&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025019742&partnerID=8YFLogxK

M3 - Article

C2 - 1688793

AN - SCOPUS:0025019742

VL - 126

SP - 1305

EP - 1307

JO - Endocrinology

JF - Endocrinology

SN - 0013-7227

IS - 2

ER -